» Articles » PMID: 9753136

VIP and PACAP Potentiate the Action of Glutamate on BDNF Expression in Mouse Cortical Neurones

Overview
Journal Eur J Neurosci
Specialty Neurology
Date 1998 Sep 30
PMID 9753136
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

In view of the neurotrophic effect of vasoactive intestinal peptide (VIP), the regulation of brain-derived neurotrophic factor (BDNF) expression by VIP and the related peptide pituitary adenylate cyclase-activating polypeptide (PACAP) was analysed by Northern blot in primary cultures of cortical neurones. Results reported in this article demonstrate that VIP and PACAP stimulate the expression of BDNF mRNA in primary cultures of cortical neurones and astrocytes. In primary cultures of cortical neurones, induction of BDNF mRNA by VIP and PACAP is completely inhibited by the N-methyl-D-aspartate (NMDA) receptor antagonists MK-801 and AP5, therefore indicating that VIP and PACAP do not stimulate BDNF expression directly but rather by potentiating the effect of glutamate tonically released by neurones and acting at NMDA receptors. In addition to its neurotrophic effects, BDNF has been shown to be involved in neuronal plasticity and results reported here suggest that by stimulating BDNF expression, VIP and PACAP could modulate synaptic plasticity in the cerebral cortex.

Citing Articles

Giant pyramidal neurons of the primary motor cortex express vasoactive intestinal polypeptide (VIP), a known marker of cortical interneurons.

Teymornejad S, Worthy K, Rosa M, Atapour N Sci Rep. 2024; 14(1):21174.

PMID: 39256434 PMC: 11387615. DOI: 10.1038/s41598-024-71637-3.


Ketamine can produce oscillatory dynamics by engaging mechanisms dependent on the kinetics of NMDA receptors.

Adam E, Kowalski M, Akeju O, Miller E, Brown E, McCarthy M Proc Natl Acad Sci U S A. 2024; 121(22):e2402732121.

PMID: 38768339 PMC: 11145256. DOI: 10.1073/pnas.2402732121.


Ketamine can produce oscillatory dynamics by engaging mechanisms dependent on the kinetics of NMDA receptors.

Adam E, Kowalski M, Akeju O, Miller E, Brown E, McCarthy M bioRxiv. 2024; .

PMID: 38617266 PMC: 11014619. DOI: 10.1101/2024.04.03.587998.


AAV-BDNF gene therapy ameliorates a hypothalamic neuroinflammatory signature in the -null model of Prader-Willi syndrome.

Queen N, Huang W, Zou X, Mo X, Cao L Mol Ther Methods Clin Dev. 2023; 31:101108.

PMID: 37766791 PMC: 10520877. DOI: 10.1016/j.omtm.2023.09.004.


Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis.

Jansen M, Broome S, Castorina A Int J Mol Sci. 2022; 23(9).

PMID: 35563181 PMC: 9104531. DOI: 10.3390/ijms23094788.